Design and regioselective synthesis of a new generation of targeted therapeutics. Part 3: Folate conjugates of aminopterin hydrazide for the treatment of inflammation

Bioorg Med Chem Lett. 2011 Feb 15;21(4):1202-5. doi: 10.1016/j.bmcl.2010.12.085. Epub 2010 Dec 22.

Abstract

Efficient syntheses of folate receptor (FR) targeting conjugates of the anti-inflammatory, aminopterin hydrazide, are described. 2-{4-Benzoylamino}-5-oxo-5-{N'-[2-(pyridin-2-yldisulfanyl)-ethoxycarbonyl]-hydrazino}-pentanoic acid is synthesized from commercially available 4-[(2-amino-4-imino-3,4-dihydro-pteridin-6-yl-methyl)-amino]-benzoic acid. Conjugation of this novel, activated aminopterin hydrazide to folic acid through cysteine-terminating (C-terminus), peptide/carbohydrate spacers results in highly water soluble conjugates which allow for the release of free aminopterin hydrazide within the endosomes of targeted cells.

MeSH terms

  • Aminopterin / chemical synthesis
  • Aminopterin / chemistry*
  • Aminopterin / therapeutic use
  • Anti-Inflammatory Agents / chemical synthesis
  • Anti-Inflammatory Agents / chemistry*
  • Anti-Inflammatory Agents / therapeutic use
  • Drug Design
  • Folic Acid / analogs & derivatives*
  • Folic Acid / chemical synthesis
  • Folic Acid / chemistry
  • Folic Acid / therapeutic use
  • Humans
  • Inflammation / drug therapy
  • Stereoisomerism

Substances

  • Anti-Inflammatory Agents
  • Folic Acid
  • Aminopterin